Cargando…
Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics
Therapy for inflammatory bowel disease (IBD) has changed, with several new agents being evaluated. The era of anti-tumor necrosis factor (anti-TNF) antibody therapy saw remarkable progress in IBD therapy. Some patients, however, do not respond to anti-TNF treatment, or their response decreases over...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial Office of Gut and Liver
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491079/ https://www.ncbi.nlm.nih.gov/pubmed/28486793 http://dx.doi.org/10.5009/gnl16308 |